TCH346
From Self-sufficiency
This article is an orphan, as few or no other articles link to it. Please introduce links to this page from related articles; suggestions may be available. (November 2006) |
TCH346 is a drug currently in clinical trials that is used to help treat Amyotrophic Lateral Sclerosis (ALS). Though this drug is still in testing, it is felt to be a work in progres, and it is widely thought that it will be a great advancement in medical sciences.
External Reference
- Neurological Institute of New York Columbia University
- National Center for Biotechnology Information article
 |
This pharmacology-related article is a stub. You can help ssf by expanding it. |
